KOBAYASHI Healthcare Australia is announcing the following release on behalf of KOBAYASHI Pharmaceutical Co., Ltd. for the customers in Australia.

Request for discontinuation of use of “Beni-koji (紅麹)” related products and notice of voluntary recall

KOBAYASHI Healthcare Australia Pty Ltd will release the following statement to assist the voluntary products recalling of Kobayashi Pharmaceutical Co., Ltd. which is related to the use of "Beni-Koji" ingredient.

KOBAYASHI Pharmaceutical Co., Ltd. (Head office: Osaka, Japan; President: Akihiro Kobayashi) has received a report that kidney problems have occurred in those who consumed “Beni-koji Cholestehelp”, a food with functional claims marketed by us. In response, we conducted an ingredient analysis of this product and the “Beni-koji” ingredients used in it (manufactured by us) where we found that some of the “Beni-koji” ingredients may contain components that we did not anticipate.

At this point in time, we have not been able to identify the exact ingredient, nor have we been able to clearly identify the causal relationship between this product and experiencing kidney problems. However, as a precautionary measure to prevent the spread of health hazards to our customers, we have decided to voluntarily recall the “Beni-koji” related products listed below as Subject Products. We deeply apologize for any inconvenience this may cause to our customers and other concerned parties. We consider this to be a serious matter and will continue to investigate.

Customers in Australia

For customers who have any of the Subject Products listed, we ask that you please discontinue the use of the product and refrain from consuming it in the future. In addition, for customers who have consumed the Subject Products and feel any physical discomfort, please contact us. NOTE: KOBAYASHI is not selling these products in Australia

If you receive information or inquiry from your customers or consumer for this incident, please contact us accordingly. Also, you can inform the contact below if your customers or consumers preferred to contact us directly. We will provide you with information on how to return the products and the method for refunds. For more information about our privacy policy please click here

Email: info.au@kobayashi.com
KOBAYASHI Healthcare Australia Pty Ltd
214/757 Bourke Street, Docklands, Victoria


According to the announcement from Kobayashi Pharmaceutical Co., Ltd., this voluntary recall involves the following three products:

recall products

Thank you very much for your understanding and support.

KOBAYASHI Healthcare Australia Pty Ltd
April 4th, 2024